Evidence map›Paper›PMID 35469375›Full record

ArticleMedical & biological engineering & computing2022

Building a predictive model to identify clinical indicators for COVID-19 using machine learning method.

Xinlei Deng, Han Li, Xin Liao, Zhiqiang Qin, Fan Xu, Samantha Friedman, Gang Ma, Kun Ye, Shao Lin

Open access · bronzeAbstract read
In one paragraph

Article in Medical & biological engineering & computing, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.3field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Albumin Is a Component of the Esterase Status of Human Blood Plasma.International journal of molecular sciences · 2023
    Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Xinlei Deng *Department of Environmental Health Sciences, School of Public Health, University at Albany, State University of New York, Rensselaer, NY, USA.
Han Li *Department of Hematology, Guangxi Academy of Medical Sciences & The People's Hospital Of Guangxi Zhuang Autonomous Region, Nanning, China.
Xin LiaoDepartment of Scientific Research, Guangxi Academy of Medical Sciences & The People's Hospital Of Guangxi Zhuang Autonomous Region, Nanning, China.
Zhiqiang QinDepartment of Respiratory, Guangxi Academy of Medical Sciences & The People's Hospital Of Guangxi Zhuang Autonomous Region, Nanning, China.
Fan XuGuangxi Health Commission Key Laboratory of Ophthalmology and Related Systemic Diseases Artificial Intelligence Screening Technology & Research Center of Ophthalmology, Guangxi Academy of Medical Sciences & The People's Hospital Of Guangxi Zhuang Autonomous Region, Nanning, China.
Samantha FriedmanDepartment of Sociology, University at Albany, State University of New York, Albany, NY, USA.
Gang MaDepartment of Obstetrics and Gynecology, Guangxi Academy of Medical Sciences & The People's Hospital Of Guangxi Zhuang Autonomous Region, Nanning, China.
Kun YeDepartment of Nephrology, Guangxi Academy of Medical Sciences & The People's Hospital Of Guangxi Zhuang Autonomous Region, Nanning, China. yezi5729@163.com.
Shao LinDepartment of Environmental Health Sciences, School of Public Health, University at Albany, State University of New York, Rensselaer, NY, USA. slin@albany.edu.
The People's Hospital of Guangxi Zhuang Autonomous Region · CNUniversity at Albany, State University of New York · US

Funding

Guangxi Critical Infectious Disease Center 2020281Nanning Science and Technology Foundation 2018030
6 · The paper itself

Abstract

Although some studies tried to identify risk factors for COVID-19, the evidence comparing COVID-19 and community-acquired pneumonia (CAP) is inconclusive, and CAP is the most common pneumonia with similar symptoms as COVID-19. We conducted a case-control study with 35 routine-collected clinical indicators and demographic factors to identify predictors for COVID-19 with CAP as controls. We randomly split the dataset into a training set (70%) and testing set (30%). We built Explainable Boosting Machine to select the important factors and built a decision tree on selected variables to interpret their relationships. The top five individual predictors of COVID-19 are albumin, total bilirubin, monocyte count, alanine aminotransferase, and percentage of monocyte with the importance scores ranging from 0.078 to 0.567. The top systematic predictors for COVID-19 are liver function, monocyte increasing, plasma protein, granulocyte, and renal function (importance scores ranging 0.009-0.096). We identified five combinations of important indicators to screen COVID-19 patients from CAP patients with differentiating abilities ranging 83.3-100%. An online predictive tool for our model was published. Certain clinical indicators collected routinely from most hospitals could help screen and distinguish COVID-19 from CAP. While further verification is needed, our findings and predictive tool could help screen suspected COVID-19 cases.

Indexed as

COVID-19PneumoniaCase-Control StudiesHumansMachine LearningRisk FactorsCommunity-acquired pneumoniaCOVID-19Machine learningPredictor

Identifiers

PMID35469375
PMCPMC9037972
OpenAlexW4224312772

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.